Print

Amyloid-blocking drug poised for approval for rare disease.

Dr. David Teplow, Professor of Neurology, Director of Biopolymer Laboratory, and the Interim Director of the Mary S. Easton Center for Alzheimer's Disease Research at UCLA, was quoted in the August 19 Alzheimer's Research Forum about amyloid-blocking drug poised for approval for rare disease.

"Amyloid-blocking drug poised for approval for rare disease"